Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

Yuzo Suzuki, Masato Karayama, Tomohiro Uto, +19

Journal of Thoracic Oncology

Autoimmune DiseaseMulticenter Prospective StudyAdvanced Lung DiseaseMedicineImmune Checkpoint Inhibitors +10

RSPO fusion transcripts in colorectal cancer in Japanese population

Kazuya Shinmura, Tomoaki Kahyo, Hisami Kato, +10

Molecular Biology Reports

MedicineColorectal CancerPathologyRspo Fusion TranscriptsGene Expression +2

<scp>YB</scp>‐1 promotes transcription of <i>cyclin D1</i> in human non‐small‐cell lung cancers

Masanori Harada, Yojiro Kotake, Tatsuya Ohhata, +7

Genes to Cells

Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification

Yusuke Inoue, Shun Matsuura, Nobuya Kurabe, +9

Journal of Thoracic Oncology

Pik3ca Gene AmplificationMedicinePathologyCancer GenomicsBronchial Neoplasm +4

Reduced expression of MUTYH with suppressive activity against mutations caused by 8‐hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer

Kazuya Shinmura, Masanori Goto, Masaya Suzuki, +8

The Journal of Pathology

Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer

Masato Karayama, Naoki Inui, Yusuke Inoue, +22

Cancer Immunology Immunotherapy

Aberrant Expression and Mutation-Inducing Activity of AID in Human Lung Cancer

Kazuya Shinmura, Hisaki Igarashi, Masanori Goto, +11

Annals of Surgical Oncology

Mutation-inducing ActivityOncologyOncogenic AgentMedicineAberrant Expression +11

A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion

Tomoaki Kahyo, Moriya Iwaizumi, Kazuya Shinmura, +5

Oncogene

Genome InstabilityCell DivisionMedicineAbnormal MitosisPathology +5

SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers

Shun Matsuura, Tomoaki Kahyo, Kazuya Shinmura, +13

Scientific Reports

Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting

Kazuki Tanaka, Naoki Inui, Masato Karayama, +14

Cancer Chemotherapy and Pharmacology

Carboplatin-induced NauseaMedicinePsychotropic MedicationNeuropharmacologyPharmacotherapy +4